Ubs Global Asset Management Americas »

Bridgebio Pharma shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 660k 40.37
2023-09-30 $18M 696k 26.37
2023-06-30 $12M 705k 16.58
2023-03-31 $12M 705k 16.58
2022-12-31 $792k 104k 7.62
2022-09-30 $1.1M 108k 9.94
2022-06-30 $769k 85k 9.08
2022-03-31 $664k 66k 10.15
2021-12-31 $1.1M 65k 16.68
2021-09-30 $3.3M 71k 46.87
2021-06-30 $4.2M 69k 60.96
2021-03-31 $2.4M 39k 61.60
2020-12-31 $6.5M 174k 37.52
2020-09-30 $6.5M 174k 37.52
2020-06-30 $5.8M 177k 32.61
2020-03-31 $4.9M 169k 29.00
2019-12-31 $2.7M 77k 35.05
2019-09-30 $1.7M 77k 21.47
2019-06-30 $2.0M 75k 26.97